药剂科持续质量改进对高危药品管理质量及安全用药的影响

Influence of continuous quality improvement of pharmacy department on the management quality of high-risk drugs and safety of medication

  • 摘要: 目的 探讨药剂科持续质量改进对高危药品管理质量及安全用药的影响。 方法 回顾性分析本院2018年1月—2019年12月药剂科高危药品日常管理情况,其中2018年1—12月实施常规管理法(常规管理组),2019年1—12月实施持续质量改进法(持续质量改进组)。比较常规管理期间和持续质量改进期间高危药品管理质量、安全用药情况及不良事件发生情况。 结果 持续质量改进组不规范行为发生率低于常规管理组,差异有统计学意义(P<0.05); 持续质量改进组高危药品知识评分为(95.14±3.52)分,高于常规管理组(74.11±4.87)分,差异有统计学意义(P<0.01); 持续质量改进组不良事件总发生率低于常规管理组,差异有统计学意义(P<0.05)。 结论 药剂科持续质量改进可完善高危药品的管理制度,能够有效提高高危药品管理质量,增强医护人员对高危药品安全用药意识,提高安全用药能力,减少不良事件。

     

    Abstract: Objective To explore the effect of continuous quality improvement of the pharmacy department on the management quality and safe use of high-risk drugs. Methods The daily management conditions of high-risk drugs in pharmacy department of our hospital from January 2018 to December 2019 were retrospectively analyzed, drugs with routine management from January to December 2018 were selected as routine management group, and those with continuous quality improvement from January to December 2019 were selected as continuous quality improvement group. The management quality, safe use of high-risk drugs and the occurrence of adverse events were compared between routine management period and continuous quality improvement period. Results The incidence of irregular behaviors in the continuous quality improvement group was lower than that in the conventional management group, and the difference was statistically significant(P<0.05); the knowledge score of the high-risk drugs in the continuous quality improvement group was higher than that in the conventional management group, the difference was statistically significant [(95.14±3.52)versus(74.11±4.87), P<0.01); the total incidence of adverse events in the continuous quality improvement group was lower than that in the conventional management group, and the difference was statistically significant(P<0.05). Conclusion The continuous quality improvement of the pharmacy department can strengthen the management system of high-risk drugs, effectively improve the management quality of high-risk drugs, enhance the medical staff's awareness of the safe use of high-risk drugs, improve the ability of safe medication, and reduce the adverse events.

     

/

返回文章
返回